Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2011; 17(40): 4542-4544
Published online Oct 28, 2011. doi: 10.3748/wjg.v17.i40.4542
Published online Oct 28, 2011. doi: 10.3748/wjg.v17.i40.4542
Figure 1 Subgroup comparison of neoadjuvant chemotherapy or neoadjuvant chemotherapy plus adjuvant chemotherapy vs surgery alone for locally advanced gastric cancer (based on the published meta-analysis and excluding the trials contaminated with adjuvant chemotherapy in control arm)[1].
M-H: Mantel-Haenszel test. NAC: Neoadjuvant chemotherapy; AC: Adjuvant chemotherapy.
Figure 2 Funnel plot analysis of publication bias.
OR: Odds ratio; NAC: Neoadjuvant chemotherapy; AC: Adjuvant chemotherapy.
- Citation: Chen XZ, Yang K, Liu J, Chen XL, Hu JK. Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer. World J Gastroenterol 2011; 17(40): 4542-4544
- URL: https://www.wjgnet.com/1007-9327/full/v17/i40/4542.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i40.4542